価格表
在庫・価格 : 2025年10月17日 07時38分 現在
商品名 | 商品コード | メーカー | 包装 | 価格 | 在庫 | リスト |
---|---|---|---|---|---|---|
FGF-9, Human, Recombinant <Fibroblast Growth Factor-9> データシート |
273-F9-025 |
RSDアールアンドディー システムズ R&D Systems, Inc. |
25 μg | ¥54,000 | 1個 | 追加 |
在庫・価格 : 2025年10月17日 07時38分 現在
使用文献
- No.: 1
-
文献情報:
Schmahl J et al. Fgf9 induces proliferation and nuclear localization of FGFR2 in Sertoli precursors during male sex determination. Development 2004 Aug;131(15):3627-36
Schmahl J et al
2004/01/01
-
備考:
Application: Bioassay, Sample Type: Whole Tissue -
参照:
- No.: 2
-
文献情報:
Kettunen P et al. Coordination of trigeminal axon navigation and patterning with tooth organ formation: epithelial-mesenchymal interactions, and epithelial Wnt4 and Tgfbeta1 regulate semaphorin 3a expression in the dental mesenchyme. Development 2005 Jan;
Kettunen P et al
2005/01/01
-
備考:
Application: Bioassay, Sample Type: Whole Tissue -
参照:
- No.: 3
-
文献情報:
Cinaroglu A et al. Expression and possible function of fibroblast growth factor 9 (FGF9) and its cognate receptors FGFR2 and FGFR3 in postnatal and adult retina. J. Neurosci. Res. 2005 Feb;79(3):329-39
Cinaroglu A et al
2005/01/01
-
備考:
Application: Bioassay, Sample Type: Whole Cells -
参照:
- No.: 4
-
文献情報:
Shiraki N et al. TGF-beta signaling potentiates differentiation of embryonic stem cells to Pdx-1 expressing endodermal cells. Genes Cells 2005 Jun;10(6):503-16
Shiraki N et al
2005/01/01
-
備考:
Application: Bioassay, Sample Type: Whole Cells -
参照:
- No.: 5
-
文献情報:
Hendrix ND et al. Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas. Cancer Res. 2006 Feb;66(3):1354-62
Hendrix ND et al
2006/01/01
-
備考:
Sample Type: Whole Cells -
参照:
- No.: 6
-
文献情報:
Shirasaki R et al. FGF as a target-derived chemoattractant for developing motor axons genetically programmed by the LIM code. Neuron 2006 Jun;50(6):841-53
Shirasaki R et al
2006/01/01
-
備考:
Species: Mouse, Application: Bioassay, Sample type: Whole Tissue -
参照:
- No.: 7
-
文献情報:
Hatch NE et al. Intracellular retention, degradation, and signaling of glycosylation-deficient FGFR2 and craniosynostosis syndrome-associated FGFR2C278F. J. Biol. Chem. 2006 Sep;281(37):27292-305
Hatch NE et al
2006/01/01
-
備考:
Species: Human, Application: Bioassay, Sample type: Whole Cells -
参照:
- No.: 8
-
文献情報:
Nakayama T et al. FGF2 posttranscriptionally down-regulates expression of SDF1 in bone marrow stromal cells through FGFR1 IIIc. Blood 2007 Feb;109(4):1363-72
Nakayama T et al
2007/01/01
-
備考:
Species: Mouse, Application: Bioassay, Sample type: Whole Cells -
参照:
- No.: 9
-
文献情報:
Bagheri-Fam S et al. Loss of Fgfr2 leads to partial XY sex reversal. Dev. Biol. 2008 Feb;314(1):71-83
Bagheri-Fam S et al
2008/01/01
-
備考:
Species: Mouse, Application: in situ binding, Whole Tissue -
参照:
- No.: 10
-
文献情報:
Wang CK et al. Aryl hydrocarbon receptor activation and overexpression upregulated fibroblast growth factor-9 in human lung adenocarcinomas. Int. J. Cancer 2009 Aug;125(4):807-15
Wang CK et al
2009/01/01
-
備考:
Application: Bioassay, Sample Type: Whole Cells -
参照:
- No.: 11
-
文献情報:
Tomlinson DC et al. Altered splicing of FGFR1 is associated with high tumor grade and stage and leads to increased sensitivity to FGF1 in bladder cancer. Am. J. Pathol. 2010 Nov;177(5):2379-86
Tomlinson DC et al
2010/01/01
-
備考:
Application: Bioassay, Sample Type: Whole Cells -
参照:
- No.: 12
-
文献情報:
Frontini MJ et al. Fibroblast growth factor 9 delivery during angiogenesis produces durable, vasoresponsive microvessels wrapped by smooth muscle cells. Nat. Biotechnol. 2011 May;29(5):421-7
Frontini MJ et al
2011/01/01
-
備考:
Application: In Vivo, Sample Type: In Vivo -
参照:
- No.: 13
-
文献情報:
Teishima J et al. Relationship between the localization of fibroblast growth factor 9 in prostate cancer cells and postoperative recurrence. Prostate Cancer Prostatic Dis. 2012 Mar;15(1):8-14
Teishima J et al
2012/01/01
-
備考:
Application: Bioassay, Sample Type: Whole Cells -
参照:
- No.: 14
-
文献情報:
Lam AQ et al. Rapid and efficient differentiation of human pluripotent stem cells into intermediate mesoderm that forms tubules expressing kidney proximal tubular markers. J. Am. Soc. Nephrol. 2014 Jun;25(6):1211-25
Lam AQ et al
2014/01/01
-
備考:
Application: Bioassay, Sample Type: Whole Cells -
参照:
- No.: 15
-
文献情報:
Lai MS et al. Fibroblast growth factor 9 activates akt and MAPK pathways to stimulate steroidogenesis in mouse leydig cells. PLoS ONE 2014;9(3):e90243
Lai MS et al
2014/01/01
-
備考:
Application: Bioassay, Sample Type: Whole Cells -
参照:
- No.: 16
-
文献情報:
Taguchi A et al. Redefining the in vivo origin of metanephric nephron progenitors enables generation of complex kidney structures from pluripotent stem cells. Cell Stem Cell 2014 Jan;14(1):53-67
Taguchi A et al
2014/01/01
-
備考:
Application: Bioassay, Sample Type: Whole Cells -
参照:
- No.: 17
-
文献情報:
Meier F et al. FGF/FGFR2 signaling regulates the generation and correct positioning of Bergmann glia cells in the developing mouse cerebellum. PLoS ONE 2014;9(7):e101124
Meier F et al
2014/01/01
-
備考:
Application: cell culture, Sample Type: Whole Cell -
参照:
- No.: 18
-
文献情報:
Sun C et al. FGF9 from cancer-associated fibroblasts is a possible mediator of invasion and anti-apoptosis of gastric cancer cells. BMC Cancer 2015;15:333
Sun C et al
2015/01/01
-
備考:
Application: Bioassay, Sample Type: Whole Cells -
参照:
- No.: 19
-
文献情報:
Yin H et al. Fibroblast Growth Factor 9 Imparts Hierarchy and Vasoreactivity to the Microcirculation of Renal Tumors and Suppresses Metastases. J. Biol. Chem. 2015 Sep;290(36):22127-42
Yin H et al
2015/01/01
-
備考:
Application: Bioassay, Sample Type: Whole Cells -
参照: